Yi Young-Su
Department of Life Sciences, Kyonggi University, Suwon, Republic of Korea.
Neuroimmunomodulation. 2021;28(4):195-203. doi: 10.1159/000516064. Epub 2021 May 27.
Inflammasomes are intracellular protein complexes consisting of the pattern recognition receptors and inflammatory molecules in the inflamed cells. In response to various ligands, inflammasomes play a pivotal role to execute the inflammatory responses by inducing the pyroptosis and the secretion of pro-inflammatory cytokines, interleukin (IL)-1β, and IL-18. Unlike canonical inflammasomes, including NOD-like receptor family inflammasomes, such as NLRP1, NLRP3, NLRC4, and absence in melanoma 2 inflammasomes, noncanonical inflammasomes, such as mouse caspase-11 and human caspase-4/5 were recently discovered, and their roles in the inflammatory responses have been poorly understood. However, emerging studies have been successfully demonstrating the regulatory roles of these noncanonical inflammasomes on inflammatory responses and the pathogenesis of inflammatory/autoimmune diseases. This review summarizes and discusses the recent studies investigating the regulatory roles of the caspase-11 noncanonical inflammasome in neuroinflammation and the pathogenesis of multiple sclerosis (MS), which provides the insight for the validation of caspase-11 noncanonical inflammasome to develop novel and promising therapeutics for MS.
炎性小体是由炎症细胞中的模式识别受体和炎症分子组成的细胞内蛋白复合物。响应各种配体时,炎性小体通过诱导细胞焦亡和促炎细胞因子白细胞介素(IL)-1β和IL-18的分泌,在执行炎症反应中起关键作用。与包括NOD样受体家族炎性小体(如NLRP1、NLRP3、NLRC4和黑色素瘤缺失2炎性小体)在内的经典炎性小体不同,非经典炎性小体(如小鼠半胱天冬酶-11和人半胱天冬酶-4/5)最近被发现,它们在炎症反应中的作用尚不清楚。然而,新出现的研究已成功证明这些非经典炎性小体对炎症反应及炎症/自身免疫性疾病发病机制的调节作用。本综述总结并讨论了最近关于半胱天冬酶-11非经典炎性小体在神经炎症和多发性硬化症(MS)发病机制中的调节作用的研究,这为验证半胱天冬酶-11非经典炎性小体以开发针对MS的新型且有前景的治疗方法提供了见解。